HIGHLIGHTS
- who: Joice Zuckermann and collaborators from the Graduate Program in Pharmacology and Therapeutics, Universidade Federal do Rio Grande do Sul, Porto Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil have published the research work: Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis, in the Journal: PLOS ONE of 19/Nov/2022
- what: Since the best dose has not been defined yet this study aimed to determine the efficacy and safety of different doses of ATG in Allo-HSCT. sources were MEDLINE/PUBMED . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.